ARTICLE | Clinical News
Pegasys peginterferon alfa-2a regulatory update
August 16, 2010 7:00 AM UTC
The U.K.'s NICE issued a final appraisal determination (FAD) recommending use of peginterferon alfa and ribavirin to treat chronic HCV infection in non-responding or relapsed adults after receiving th...